OUP Management Co., LLC
- SEC CIK
- 0001880124
- Latest filing
- Nov 9, 2023
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 4, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 16
- 0 vs. Q4 2021
- Portfolio value
- $131.3M
- −$90.5M (−40.8%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IONQIonQ, Inc. | COM | 2,319,519 | $29.6M | 22.5% | −1,827,562−44.1% | Reduced | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,937,615 | $26.4M | 20.1% | +595,724+25.4% | Added | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 989,232 | $20.6M | 15.7% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 603,762 | $11.1M | 8.4% | 00.0% | Unchanged | History |
| DICEDICE Therapeutics, Inc. | COM | 536,693 | $10.3M | 7.8% | 00.0% | Unchanged | History |
| CYTCyteir Therapeutics, Inc. | COM | 2,474,572 | $9.33M | 7.1% | 00.0% | Unchanged | History |
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 1,820,866 | $4.83M | 3.7% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 1,025,697 | $4.11M | 3.1% | 00.0% | Unchanged | History |
| DTILPrecision Biosciences Inc | COM | 1,123,913 | $3.46M | 2.6% | 00.0% | Unchanged | History |
| LABPLandos Biopharma, Inc. | COM | 1,827,478 | $2.70M | 2.1% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 374,714 | $2.26M | 1.7% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 249,070 | $2.17M | 1.6% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 406,308 | $2.07M | 1.6% | 00.0% | Unchanged | History |
| SERASera Prognostics, Inc. | CLASS A COM | 337,505 | $1.28M | 1.0% | −303,856−47.4% | Reduced | History |
| RNACCartesian Therapeutics, Inc. | COM | 862,543 | $1.06M | 0.8% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 64,000 | $195.0K | 0.1% | 00.0% | Unchanged | History |